ConductScience.org, home

Paper14729660

mRNA is an endogenous ligand for Toll-like receptor 3.

Karikó K and 4 others. J Biol Chem, 2004. Cited by 863 papers, by iCite.

Cite this record

ConductScience Library. mRNA is an endogenous ligand for Toll-like receptor 3. Papers, record 14729660. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14729660

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
mRNA is an endogenous ligand for Toll-like receptor 3.
PubMed
Journal
J Biol Chem
PubMed
Year
2004
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
863
iCite
Relative citation ratio, by iCite
16.3
iCite
Revised in PubMed
2022-03-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Karikó KKatalin
2Ni HHouping
3Capodici JJohn
4Lamphier MMarc
5Weissman DDrew

Source PubMed

Download CSV of authors

Topics31

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Membrane GlycoproteinsMajor topic
Receptors, Cell SurfaceMajor topic
Blotting, Northern
Cell Line
Dendritic Cells
Dose-Response Relationship, Drug
Enzyme Inhibitors
Enzyme-Linked Immunosorbent Assay
Genistein
Humans
Interleukin-1 Receptor-Associated Kinases
Interleukin-8
Ligands
Luciferases
NF-kappa B
Necrosis
Nucleic Acid Conformation
Plasmids
Protein Kinases
RNA
RNA, Double-Stranded
RNA, Messenger
Signal Transduction
Staurosporine
Toll-Like Receptor 3
Toll-Like Receptors
Transcription, Genetic
Transfection
Tumor Necrosis Factor-alpha
Tyrosine
Up-Regulation

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI 50484NIAID NIH HHSUnited StatesR01AI050484PubMed and NIHNIH RePORTER
HL 62060-04NHLBI NIH HHSUnited StatesPubMedPubMed
R01HL062060NIHNIH RePORTER

Download CSV of grants

Cited by457

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 863 citations.

PMIDTitleJournalYearIn PapersSource
42853631mRNA-based therapies: From molecular discovery to clinical revolution.Genet Mol Biol2026https://conductscience.org/library/papers/42853631PubMed
42764981Lipid nanoparticles as active biointerfaces: From membrane interaction to systemic dysregulation.Acta Pharm Sin B2026https://conductscience.org/library/papers/42764981PubMed
42460750Cancer Vaccine Development: Toward Artificial Intelligence-Assisted Personalized Cell Membrane Nanovaccine.Small2026https://conductscience.org/library/papers/42460750PubMed
42344670Engineering bone tissue with mRNA: from molecular design and delivery to clinical applications.Mater Today (Kidlington)2025https://conductscience.org/library/papers/42344670PubMed
42321218Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancer.Nat Commun2026https://conductscience.org/library/papers/42321218PubMed
42294684IFN-I exacerbates the inflammatory response of epithelial cells to Chlamydia trachomatis infection by enhancing TLR3 expression.mBio2026https://conductscience.org/library/papers/42294684PubMed
42125067mRNA Lipid Nanoparticles for Cell Engineering in Vivo and in Vitro: Current Applications and Future Directions.MedComm (2020)2026https://conductscience.org/library/papers/42125067PubMed
42076082RNA Therapeutics in Viral Infections and Cancer: Mechanisms, Challenges, and Prospects: A Review.Pharmaceutics2026https://conductscience.org/library/papers/42076082PubMed
41943009A comprehensive analysis of the use of nucleoside analogues in RNA therapeutics.J Transl Med2026https://conductscience.org/library/papers/41943009PubMed
41769202Nucleic acid-based therapeutics to restore joint homeostasis in age-related and post-traumatic arthritis.NPJ Biomed Innov2026https://conductscience.org/library/papers/41769202PubMed
41750365mRNA-Encoded Antibodies: An Emerging Paradigm in Antiviral Protection.Biomolecules2026https://conductscience.org/library/papers/41750365PubMed
41732665Effect of type I collagen on TLR-3 induced MMP-13 expression in human periodontal ligament fibroblasts.J Oral Biol Craniofac Res2026https://conductscience.org/library/papers/41732665PubMed
41600889Making Sense from Structure: What the Immune System Sees in Viral RNA.Viruses2026https://conductscience.org/library/papers/41600889PubMed
41479562mRNA-Based Personalized Cancer Vaccines: Opportunities, Challenges and Outcomes.Acta Naturae2025https://conductscience.org/library/papers/41479562PubMed
41155941RNA Therapeutics: Delivery Problems and Solutions-A Review.Pharmaceutics2025https://conductscience.org/library/papers/41155941PubMed
41098300Impact of Allostatic Load on Chronic Hepatitis B and C: A Narrative Review.Cureus2025https://conductscience.org/library/papers/41098300PubMed
41053377Sterile inflammation in MASH: emerging role of extracellular RNA and therapeutic strategies.NPJ Metab Health Dis2025https://conductscience.org/library/papers/41053377PubMed
40969676Harnessing mRNA-lipid nanoparticles as innovative therapies for autoimmune diseases.Mol Ther Methods Clin Dev2025https://conductscience.org/library/papers/40969676PubMed
40905915Using modified mRNA for cardiomyocyte proliferation and cardiac genetic disease modelling and treatment.Biochem Soc Trans2025https://conductscience.org/library/papers/40905915PubMed
40881859Unraveling the potential: mRNA therapeutics in oncology.Front Oncol2025https://conductscience.org/library/papers/40881859PubMed

See all 457 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
IRF13659PubTator's text mininghttps://conductscience.org/library/genes/3659NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
TLR37098PubTator's text mininghttps://conductscience.org/library/genes/7098NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14729660

GET https://conductscience.org/api/papers/v1/14729660/cited_by?page=2